CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products

This publication has 65 references indexed in Scilit:

• Expression of Macrophage (Mφ) Scavenger Receptor, CD36, in Cultured Human Aortic Smooth Muscle Cells in Association With Expression of Peroxisome Proliferator Activated Receptor-γ, Which Regulates Gain of Mφ-Like Phenotype In Vitro, and Its Implication in Atherogenesis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Advanced Glycation End Product-Induced Peroxisome Proliferator-Activated Receptor γ Gene Expression in the Cultured Mesangial Cells
  Biochemical and Biophysical Research Communications, 1999
• Identification on Human CD36 of a Domain (155-183) Implicated in Binding Oxidized Low-Density Lipoproteins (Ox-LDL)
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Oxidized LDL Binds to CD36 on Human Monocyte-Derived Macrophages and Transfected Cell Lines
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Angiogenic Effects of Advanced Glycation End Products of the Maillard Reaction on Cultured Human Umbilical Cord Vein Endothelial Cells
  Biochemical and Biophysical Research Communications, 1993
• Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.
  Journal of Clinical Investigation, 1993
• Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.
  Journal of Clinical Investigation, 1992
• Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.
  The Journal of Experimental Medicine, 1991
• Isolation of the thrombospondin membrane receptor.
  Journal of Clinical Investigation, 1987
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970